Clinical Trial Update: Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating aspirin to prevent recurrence in node-positive HER2-negative breast cancer after standard therapy was terminated; results posted in 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Aspirin (Aspirin)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Node Positive HER2 Negative Breast Cancer | Phase 3 | Status: TERMINATED | Results posted: 2023-03-27